Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I

Arthritis and Rheumatism

Volumn 43, Issue 7, 2000, Pages 1624-1632

  Rosenbloom, Joel ^a   Saitta, Biagio ^b   Gaidarova, Svetlana ^b   Sandorfi, Nora ^b   Rosenbloom, Joan C ^a   Abrams, William R ^a   Hamilton, Andrew D ^c   Sebti, Said M ^d   Kucich, Umberto ^a   Jimenez, Sergio A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHLORAMPHENICOL ACETYLTRANSFERASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYCLOOXYGENASE 1; FIBRONECTIN; GGTI 298; GGTI 928; MESSENGER RNA; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRUCTURE; CELL VIABILITY; COLLAGEN SYNTHESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

EID: 0033919245     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200007)43:7<1624::AID-ANR28>3.0.CO;2-E     Document Type: Article

References (36)

1. Medsger TA Jr. Systemic sclerosis (scleroderma): clinical aspects. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. Baltimore: Williams and Wilkins; 1997. p. 1433-63.
2. Wigley FM. Systemic sclerosis. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1998. p. 9.1-9.14.
3. Batuman OA, Jimenez SA. The molecular pathology of autoimmune diseases, Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, editors. Chur (Switzerland): Harwood Academic Publishers; 1993. p. 377.
4. Sackner MA. Scleroderma, modern medical monographs. New York: Grune and Stratton; 1996.
5. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
6. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
7. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974;54:880-9.
8. Uitto J, Bauer EA, Eisen AZ. Scleroderma: increased biosynthesis of triple-helical type I and type III procollagcns associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest 1979;64:921-32.
9. Kähäri V, Vuorio T, Nanto-Salonen K, Vuorio E. Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta 1984;781:183-6.
10. Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis. Biochem J 1986; 237:837-43.
11. Peltonen J, Kähäri L, Uitto J, Jimenez SA. Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum 1990;33:1829-35.
12. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Uitto J. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis: regulation by transforming growth factor-β. J Clin Invest 1994;93:1709-15.
13. Kikuchi K, Smith EA, LeRoy EC, Trojanowska M. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts. Biochem Biophys Res Commun 1992;187:45-50.
14. Hitraya EG, Jiménez SA. Transcriptional activation of the α1(I) procollagen gene in systemic sclerosis dermal fibroblasts: role of intronic sequences. Arthritis Rheum 1996;39:1347-54.
15. Kucich U, Rosenbloom JC, Abrams WR, Bashir MM, Rosenbloom J. Stabilization of elastin mRNA by TGF-β: initial characterization of signaling pathway. Am J Respir Cell Mol Biol 1997;17:10-6.
16. Waseem A, Kucich U, Abrams W, Bashir M, Rosenbloom JC, Segade F, et al. Signaling pathway by which TGF-β1 increases expression of latent TGF-β binding protein-2 at the transcriptional level. Connect Tissue Res 1998;37:263-76.
17. Kucich U, Rosenbloom JC, Shen G, Abrams WR, Blaskovich MA, Hamilton AD, et al. Requirement for geranylgeranyl transferase I and acyl transferase in the TGF-β-stimulated pathway leading to elastin mRNA stabilization. Biochem Biophys Res Commun 1998; 252:111-6.
18. Lerner EC, Qian C, Hamilton AD, Sebti SM. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyl-transferase I inhibitor. J Biol Chem 1995;270: 26770-3.
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
20. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984;74:1112-6.
21. Vogt A, Qian Y, Hamilton AD, Sebti SM. Protein geranylgeranylation not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene 1996;13:1991-9.
22. Bellon G. Quantification and specific detection of collagenous proteins using an enzyme-linked immunosorbent assay and an immunoblotting for cyanogen bromide peptides. Anal Biochem 1985;150:188-202.
23. Chomczynki P, Sacchi S. Single-step method of RNA isolation by acid guanidinium thio-cyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Jimenez SA, Varga J, Olsen A, Li L, Diaz A, Herhal J, et al. Functional analysis of human α1(I) procollagen gene promoter: differential activity in collagen-producing and non-producing cells and response to transforming growth factor-β1. J Biol Chem 1994;269:12684-91.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein DNA binding. Anal Biochem 1976;72:248-54.
26. Gorman CM, Moffet OS, Howard BH. Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol Cell Biol 1982;2:1044-51.
27. Shaul PW, Pace MC, Chen Z, Brannon TS. Developmental changes in prostacyclin synthesis are conserved in cultured pulmonary endothelium and vascular smooth muscle. Am J Respir Cell Mol Biol 1999;20:113-21.
28. Diaz A, Jimenez SA. Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms. Int J Biochem Cell Biol 1997;29:251-60.
29. Schafer WR, Rine J. Protein prenylation: genes, enzymes, targets, and functions. Annu Rev Genet 1992;30:209-37.
30. Seabra MC, Goldstein JL, Sudhof TC, Brown MS. Rab geranylgeranyl transferase: a multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or Cys-Cys. J Biol Chem 1992;267:14497-503.
31. McGuire TF, Qian Y, Vogt A, Hamilton AD, Sebti SM. Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. J Biol Chem 1996;271:27402-7.
32. WAF1/CIP1 is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor β- and Sp1-responsive element: involvement of the small GTPase RhoA. Mol Cell Biol 1998;18:6962-70.
33. Li L, Artlett CM, Jimenez SA, Hall DJ, Varga J. Positive regulation of human α1(I) collagen promoter activity by transcription factor Sp1. Gene 1995;164:229-34.
34. Chen SJ, Artlett CM, Jimenez SA, Varga J. Modulation of human α1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene 1998;215:101-10.
35. Artlett CM, Chen S-J, Varga J, Jimenez SA. Modulation of basal expression of the human α1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts. Matrix Biol 1998;17:425-34.
36. Hitraya EG, Varga J, Artlett CM, Jiménez SA. Identification of elements in the promoter region of the α1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum 1998;41:2048-58.